Regulatory Pathways in Borrelial Pathogenesis
伯氏疏螺旋体发病机制的调节途径
基本信息
- 批准号:10677726
- 负责人:
- 金额:$ 66.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-05 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdhesionsAffectArbovirus InfectionsArthropod VectorsAttenuatedBacteria sigma factor KatF proteinBindingBinding SitesBiochemicalBorreliaBorrelia burgdorferiBorrelia oxidative stress regulatorChIP-seqComplementComplexConsensus SequenceCysteineDNADNA BindingDNA SequenceDataDiagnosisEtiologyEventExhibitsGene ExpressionGene Expression ProfileGene Expression RegulationGenesGenetic TranscriptionGoalsHomologous GeneInfectionInfectious AgentLife Cycle StagesLinkLyme DiseaseMammalsMediatingMetalsMethodologyMolecular ChaperonesMusNucleic Acid BindingOxidation-ReductionOxidative StressPathogenesisPathogenicityPathway interactionsPersonsPhenotypePost-Transcriptional RegulationPreventionPrevention strategyProductionPromoter RegionsProteinsPublic HealthPublicationsRNARNA BindingRecording of previous eventsRegulationRegulator GenesRegulatory PathwayRegulonResearchRoleSchemeStructureTestingTherapeuticTimeTranscriptTranscriptional RegulationTranslationsUncertaintyUnited StatesUntranslated RNAVirulenceWorkarthropod-bornecrosslinking and immunoprecipitation sequencingdimerexperienceexperimental studygenetic regulatory proteininnovationinsightinterestmetalloregulatory proteinmutantnovelskillsstemtick transmissiontranscriptometranscriptome sequencingtransmission processvirulence gene
项目摘要
PROJECT SUMMARY
The etiologic agent of Lyme Disease, Borrelia burgdorferi (Bb), is the leading arthropod-borne infection in the
United States with over 470,000 cases diagnosed annually. Given that Lyme Disease is a significant public
health concern, studies addressing how Bb establishes and maintains infection are vital to evaluating its
pathogenic potential and developing prevention or therapeutic strategies. It is well known that Bb modifies its
transcriptional profile throughout its pathogenic lifecycle, particularly during transmission from the arthropod
vector into mammals. BosR is an important transcriptional regulator that functions as a global metalloregulatory
protein and alters the expression of genes needed for mammalian colonization. Specifically, BosR is required
for experimental infection in mice and is needed for the activation of the RpoS/RpoN/Rrp2 cascade that drives
the expression of genetically unlinked genes, including virulence determinants required for Bb infection. While
there is no doubt that the BosR-dependent regulation of rpoS is important to borrelial infectivity, there are
additional genes that BosR regulates either directly or indirectly that may factor into Bb infection. How BosR is
linked to this complex regulatory network has not been thoroughly addressed. Here, several novel BosR
regulatory functions are described, heretofore unknown, including the recognition of RNA by BosR. The
Preliminary Data shows that BosR binds to small non-coding RNA and exhibits chaperone activity suggesting
that BosR forms a complex with sRNAs that binds to Bb transcripts and targets them for degradation or enhanced
translation. This form of post-transcriptional regulation by BosR represents a new and innovative regulatory
scheme that adds to its known DNA binding activity. In Aim 1, a subset of sRNAs that BosR binds will be
evaluated, the transcripts recognized by the BosR::sRNA complex identified, and a link with the BosR-associated
sRNAs to borrelial pathogenesis established. In Aim 2, recent ChIP-seq data will be mined to assess novel BosR
DNA binding. Preliminary binding studies confirmed the ChIP-seq data for two targets and suggested that the
redox status and metal coordination of BosR may alter DNA binding. BosR DNA binding will be analyzed to
determine how the redox and metal binding status of BosR changes the target sequences recognized. Unique
BosR binding motifs will be tracked, and a consensus sequence ascertained. Finally, experiments will be
conducted to determine the phenotype of a bosR mutant that ectopically produces RpoS to query the direct role
of BosR in Bb infection. Taken together, this proposal will provide new appreciation into how BosR-mediated
transcriptional and post-transcriptional regulation ensues and novel insight into how BosR integrates the redox
status of Bb to affect nucleic acid binding and borrelial pathogenesis.
项目概要
莱姆病的病原体伯氏疏螺旋体 (Bb) 是该地区主要的节肢动物传播的感染
美国每年确诊病例超过 47 万例。鉴于莱姆病是一种重要的公众疾病
由于健康问题,研究 Bb 如何建立和维持感染对于评估其感染至关重要
致病潜力并制定预防或治疗策略。众所周知,Bb修改了它的
整个致病生命周期的转录谱,特别是从节肢动物传播期间
载体进入哺乳动物。 BosR 是一种重要的转录调节因子,具有全局金属调节作用
蛋白质并改变哺乳动物定植所需基因的表达。具体来说,需要BosR
用于小鼠实验感染,并且是激活驱动 RpoS/RpoN/Rrp2 级联所必需的
遗传上不相关的基因的表达,包括 Bb 感染所需的毒力决定因素。尽管
毫无疑问,rpoS 的 BosR 依赖性调节对于疏螺旋体感染性很重要,有
BosR 直接或间接调节的其他基因可能会影响 Bb 感染。 BosR 怎么样
与这个复杂的监管网络相关的问题尚未得到彻底解决。这里,几个新颖的BosR
描述了迄今为止未知的调节功能,包括 BosR 对 RNA 的识别。这
初步数据显示 BosR 与小非编码 RNA 结合并表现出伴侣活性,表明
BosR 与 sRNA 形成复合物,与 Bb 转录物结合并靶向它们进行降解或增强
翻译。 BosR 的这种转录后监管形式代表了一种新的创新监管方式
方案增加了其已知的 DNA 结合活性。在目标 1 中,BosR 结合的 sRNA 子集将是
评估后,鉴定出 BosR::sRNA 复合物识别的转录本,以及与 BosR 相关的链接
sRNA 与疏螺旋体发病机制的关系已确立。在目标 2 中,将挖掘最近的 ChIP-seq 数据来评估新型 BosR
DNA 结合。初步结合研究证实了两个靶标的 ChIP-seq 数据,并表明
BosR 的氧化还原状态和金属配位可能会改变 DNA 结合。 BosR DNA 结合将被分析
确定 BosR 的氧化还原和金属结合状态如何改变识别的靶序列。独特的
BosR 结合基序将被追踪,并确定共有序列。最后将进行实验
确定异位产生 RpoS 的 bosR 突变体的表型,以探究其直接作用
Bb 感染中的 BosR。总而言之,该提案将为 BosR 介导的方式提供新的认识
转录和转录后调控随之发生,并对 BosR 如何整合氧化还原有了新的见解
Bb 的状态影响核酸结合和疏螺旋体发病机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jenny A. Hyde其他文献
Jenny A. Hyde的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jenny A. Hyde', 18)}}的其他基金
Regulatory Pathways in Borrelial Pathogenesis
伯氏疏螺旋体发病机制的调节途径
- 批准号:
10504708 - 财政年份:2022
- 资助金额:
$ 66.31万 - 项目类别:
Elucidating the Bacterial and Host Mechanisms Governing B. burgdorferi-Related Type I Interferon Responses
阐明控制伯氏疏螺旋体相关 I 型干扰素反应的细菌和宿主机制
- 批准号:
10302429 - 财政年份:2021
- 资助金额:
$ 66.31万 - 项目类别:
The role of small non-coding RNA in borrelial pathogenesis
小非编码 RNA 在疏螺旋体发病机制中的作用
- 批准号:
9090929 - 财政年份:2016
- 资助金额:
$ 66.31万 - 项目类别:
Characterization of C02 Sensing and Regulatory Response in Borrelia burgdorferi
伯氏疏螺旋体中CO2感应和调节反应的表征
- 批准号:
8715687 - 财政年份:2013
- 资助金额:
$ 66.31万 - 项目类别:
Characterization of C02 Sensing and Regulatory Response in Borrelia burgdorferi
伯氏疏螺旋体中CO2感应和调节反应的表征
- 批准号:
8583139 - 财政年份:2013
- 资助金额:
$ 66.31万 - 项目类别:
In vivo dual Bioluminescence Reporter System of Infectious Borrelia burgdorferi
传染性伯氏疏螺旋体的体内双生物发光报告系统
- 批准号:
8358909 - 财政年份:2012
- 资助金额:
$ 66.31万 - 项目类别:
In vivo dual Bioluminescence Reporter System of Infectious Borrelia burgdorferi
传染性伯氏疏螺旋体的体内双生物发光报告系统
- 批准号:
8497620 - 财政年份:2012
- 资助金额:
$ 66.31万 - 项目类别:
相似国自然基金
动脉粥样硬化发生中CAPN2影响内皮粘连的机制研究
- 批准号:82000254
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
层粘连蛋白受体第272位苏氨酸影响猪瘟病毒感染的分子机制
- 批准号:31902264
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
层粘连蛋白调控巨噬细胞和脂肪基质细胞影响肥胖脂肪组织重塑的机制
- 批准号:
- 批准年份:2019
- 资助金额:300 万元
- 项目类别:
保留双层肌膜的功能性肌肉移植中S1P/S1PR1轴调节巨噬细胞迁移及分化对移植肌肉粘连与功能的影响
- 批准号:81871787
- 批准年份:2018
- 资助金额:55.0 万元
- 项目类别:面上项目
大黄-桃仁介导AhR通路影响Th17/Treg和肠道菌群平衡改善肠粘膜屏障功能防治粘连性肠梗阻的机制研究
- 批准号:81804098
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The Role of Layilin as a Novel Regulator of Platelet Activation and Thromboinflammation
Layilin 作为血小板活化和血栓炎症的新型调节剂的作用
- 批准号:
10638243 - 财政年份:2023
- 资助金额:
$ 66.31万 - 项目类别:
Mechanisms Underpinning Afterload-Induced Atrial Fibrillation
后负荷诱发心房颤动的机制
- 批准号:
10679796 - 财政年份:2023
- 资助金额:
$ 66.31万 - 项目类别:
Mucoadhesive film for the treatment of vestibulodynia
治疗前庭痛的粘膜粘附膜
- 批准号:
10699463 - 财政年份:2023
- 资助金额:
$ 66.31万 - 项目类别:
Development of a novel disease-modifying glycan therapeutic for early at-home intervention of acute vaso-occlusive crisis in sickle cell disease
开发一种新型疾病缓解聚糖疗法,用于镰状细胞病急性血管闭塞危象的早期家庭干预
- 批准号:
10603870 - 财政年份:2023
- 资助金额:
$ 66.31万 - 项目类别:
Endothelial-Leukocyte Adhesion in CAR T Cell Treatment Associated Neurotoxicity
CAR T 细胞治疗相关神经毒性中的内皮-白细胞粘附
- 批准号:
10735681 - 财政年份:2023
- 资助金额:
$ 66.31万 - 项目类别: